HighVista Strategies LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$632,928
-38.7%
35,4780.0%0.52%
-15.8%
Q4 2022$1,033,119
+95.7%
35,478
+43.0%
0.61%
+56.4%
Q1 2021$528,000
+27.2%
24,809
+33.3%
0.39%
+14.0%
Q2 2020$415,00018,6090.34%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP, LLC 2,981,437$86,969,00072.32%
MPM ASSET MANAGEMENT LLC 3,074,893$89,695,00060.73%
Foresite Capital Management IV, LLC 696,903$20,329,0006.66%
NEA Management Company, LLC 4,912,306$143,292,0006.18%
RA Capital Management 1,950,332$56,891,0003.04%
Trustees of Princeton University 47,643$1,390,0001.96%
Greylock XII GP LLC 54,749$1,597,0001.12%
Baker Brothers Advisors 2,708,200$78,998,0000.52%
Perceptive Advisors 664,186$19,374,0000.52%
Sofinnova Investments, Inc. 159,302$4,646,0000.41%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders